Impact of Colorectal Cancer Screening Programme On Colonic Cancer Surgery Outcome In Our Institution
EAES Academy. Salama M. 07/05/22; 363006; P049
Mr. Mohamed Salama
Contributions
Contributions
Abstract
Introduction
Over the past 3 decades the number of Colorectal Cancer (CRC) cases has significantly increased in Ireland. Despite considerable improvement in CRC management, there is a great deal of variation of outcomes among European countries and particularly among different hospitals.
Aims
To evaluate the impact of CRC screening programme on patient outcome after CRC surgery in our institution.
Method
We conducted a retrospective cohort study including all patients with CRC treated at our institution between 2013 and 2018. Patients were classified into 3 subgroups: 1) Age ≤50 years 2) Age >50 and < 75 years 3) Age ≥ 75 years
Data collected: age, gender, location, stage, operation and histology.
All patients were followed for prognosis and mortality.
Results:
Total number: 342 (F:141, M:201), age range: 30-96y. Group 1: 29 (F:7, M:22), Group 2: 177 (F:65, M:112), Group 3: 136 (F:51, M:85). Tumour Location: Left: 166, Right: 176
4 patients underwent palliative treatment (3 advanced stage, 1 elderly). 29 patients (8.5%) underwent emergency surgery secondary to obstruction or perforation. (F: 14, M: 15) Age range: 41-93y.
With respect to tumour stage, 93% of Group 1, 91% of Group 2 and 86% of Group 3 presented with stage 3 or more.
Regarding the mortality: Follow-up showed that 87 out of 342[F:31 (35.6%), M:56 (64.4%)] died with a mortality rate of 25.4%. Mortality in age group 1 was 3(10.3%), group 2 was 48(27.1%) and group 3 was 36(26.4%).
Conclusion:
In our study, most of the cases were diagnosed at late stage (Stage 3 and 4). This is likely to be as a result of more comprehensive investigation in the perioperative period, resulting in a significant shift in stage allocation from stage 1 and 2 to stage 3 and 4.
The bowel screening programme in Ireland includes individuals aged 60 to 69 years. This narrow age range means that the potential benefits of screening in terms of early detection of CRC and reduction in incidence and mortality are unlikely to be achieved in the short term.
Although Irish survival has improved, it remains below the European average
Over the past 3 decades the number of Colorectal Cancer (CRC) cases has significantly increased in Ireland. Despite considerable improvement in CRC management, there is a great deal of variation of outcomes among European countries and particularly among different hospitals.
Aims
To evaluate the impact of CRC screening programme on patient outcome after CRC surgery in our institution.
Method
We conducted a retrospective cohort study including all patients with CRC treated at our institution between 2013 and 2018. Patients were classified into 3 subgroups: 1) Age ≤50 years 2) Age >50 and < 75 years 3) Age ≥ 75 years
Data collected: age, gender, location, stage, operation and histology.
All patients were followed for prognosis and mortality.
Results:
Total number: 342 (F:141, M:201), age range: 30-96y. Group 1: 29 (F:7, M:22), Group 2: 177 (F:65, M:112), Group 3: 136 (F:51, M:85). Tumour Location: Left: 166, Right: 176
4 patients underwent palliative treatment (3 advanced stage, 1 elderly). 29 patients (8.5%) underwent emergency surgery secondary to obstruction or perforation. (F: 14, M: 15) Age range: 41-93y.
With respect to tumour stage, 93% of Group 1, 91% of Group 2 and 86% of Group 3 presented with stage 3 or more.
Regarding the mortality: Follow-up showed that 87 out of 342[F:31 (35.6%), M:56 (64.4%)] died with a mortality rate of 25.4%. Mortality in age group 1 was 3(10.3%), group 2 was 48(27.1%) and group 3 was 36(26.4%).
Conclusion:
In our study, most of the cases were diagnosed at late stage (Stage 3 and 4). This is likely to be as a result of more comprehensive investigation in the perioperative period, resulting in a significant shift in stage allocation from stage 1 and 2 to stage 3 and 4.
The bowel screening programme in Ireland includes individuals aged 60 to 69 years. This narrow age range means that the potential benefits of screening in terms of early detection of CRC and reduction in incidence and mortality are unlikely to be achieved in the short term.
Although Irish survival has improved, it remains below the European average
Introduction
Over the past 3 decades the number of Colorectal Cancer (CRC) cases has significantly increased in Ireland. Despite considerable improvement in CRC management, there is a great deal of variation of outcomes among European countries and particularly among different hospitals.
Aims
To evaluate the impact of CRC screening programme on patient outcome after CRC surgery in our institution.
Method
We conducted a retrospective cohort study including all patients with CRC treated at our institution between 2013 and 2018. Patients were classified into 3 subgroups: 1) Age ≤50 years 2) Age >50 and < 75 years 3) Age ≥ 75 years
Data collected: age, gender, location, stage, operation and histology.
All patients were followed for prognosis and mortality.
Results:
Total number: 342 (F:141, M:201), age range: 30-96y. Group 1: 29 (F:7, M:22), Group 2: 177 (F:65, M:112), Group 3: 136 (F:51, M:85). Tumour Location: Left: 166, Right: 176
4 patients underwent palliative treatment (3 advanced stage, 1 elderly). 29 patients (8.5%) underwent emergency surgery secondary to obstruction or perforation. (F: 14, M: 15) Age range: 41-93y.
With respect to tumour stage, 93% of Group 1, 91% of Group 2 and 86% of Group 3 presented with stage 3 or more.
Regarding the mortality: Follow-up showed that 87 out of 342[F:31 (35.6%), M:56 (64.4%)] died with a mortality rate of 25.4%. Mortality in age group 1 was 3(10.3%), group 2 was 48(27.1%) and group 3 was 36(26.4%).
Conclusion:
In our study, most of the cases were diagnosed at late stage (Stage 3 and 4). This is likely to be as a result of more comprehensive investigation in the perioperative period, resulting in a significant shift in stage allocation from stage 1 and 2 to stage 3 and 4.
The bowel screening programme in Ireland includes individuals aged 60 to 69 years. This narrow age range means that the potential benefits of screening in terms of early detection of CRC and reduction in incidence and mortality are unlikely to be achieved in the short term.
Although Irish survival has improved, it remains below the European average
Over the past 3 decades the number of Colorectal Cancer (CRC) cases has significantly increased in Ireland. Despite considerable improvement in CRC management, there is a great deal of variation of outcomes among European countries and particularly among different hospitals.
Aims
To evaluate the impact of CRC screening programme on patient outcome after CRC surgery in our institution.
Method
We conducted a retrospective cohort study including all patients with CRC treated at our institution between 2013 and 2018. Patients were classified into 3 subgroups: 1) Age ≤50 years 2) Age >50 and < 75 years 3) Age ≥ 75 years
Data collected: age, gender, location, stage, operation and histology.
All patients were followed for prognosis and mortality.
Results:
Total number: 342 (F:141, M:201), age range: 30-96y. Group 1: 29 (F:7, M:22), Group 2: 177 (F:65, M:112), Group 3: 136 (F:51, M:85). Tumour Location: Left: 166, Right: 176
4 patients underwent palliative treatment (3 advanced stage, 1 elderly). 29 patients (8.5%) underwent emergency surgery secondary to obstruction or perforation. (F: 14, M: 15) Age range: 41-93y.
With respect to tumour stage, 93% of Group 1, 91% of Group 2 and 86% of Group 3 presented with stage 3 or more.
Regarding the mortality: Follow-up showed that 87 out of 342[F:31 (35.6%), M:56 (64.4%)] died with a mortality rate of 25.4%. Mortality in age group 1 was 3(10.3%), group 2 was 48(27.1%) and group 3 was 36(26.4%).
Conclusion:
In our study, most of the cases were diagnosed at late stage (Stage 3 and 4). This is likely to be as a result of more comprehensive investigation in the perioperative period, resulting in a significant shift in stage allocation from stage 1 and 2 to stage 3 and 4.
The bowel screening programme in Ireland includes individuals aged 60 to 69 years. This narrow age range means that the potential benefits of screening in terms of early detection of CRC and reduction in incidence and mortality are unlikely to be achieved in the short term.
Although Irish survival has improved, it remains below the European average
{{ help_message }}
{{filter}}